エピソード

  • LLY Today - Jul 15: Small Dip Amid Market Gains
    2026/07/15
    Hey there! It’s Joey, your friendly neighborhood investor, here to break down what went down with Eli Lilly today. So, LLY had a bit of a rough day, slipping about 1.2%. Yeah, that one stung.

    Now, let’s talk about what happened. While the overall market was on the upswing, LLY decided to take a step back. The volume was way lower than usual, too. People weren’t really rushing to buy or sell, which is kinda telling.

    So, why the dip? Well, there wasn’t a major news bomb that dropped, but it seems like investors are just taking a breather after a pretty solid run. There was chatter about Eli Lilly's performance compared to its peers, and it looks like some folks are getting cautious. Plus, there’s a lot of buzz about its future potential. Bernstein even raised the stock price target, which usually means someone’s feeling optimistic. But today? Not so much.

    Oh, and here’s a fun fact: Eli Lilly has been a solid performer for a while now. Back in 2020, the Atlas Healthcare Fund got in at around $350. Now, it’s trading over $1,200! Wild, right?

    To wrap it up, Eli Lilly took a small dip today while the market was cruising. It's a reminder that even good stocks have their off days. Just keep an eye on the future, as there’s still a lot of potential there. Remember, this is just for fun and info, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • LLY Today - Jul 14: Stock Takes a Dip
    2026/07/14
    Hey there! It’s Joey here, your friendly neighborhood investor. Let’s chat about Eli Lilly today. It was a red day for LLY, down about 2.7%. Ouch!

    So, what happened? Well, the stock got smoked, dropping over 30 bucks. Not the best news, right? The volume was pretty low, too, which usually means people are sitting on the sidelines.

    Now, why did this happen? There’s a lot of chatter in the market. Bernstein raised their price target, which is usually a good sign. They see potential for Lilly to beat expectations. But then there’s this disturbing trend in the obesity drug market that’s got some folks worried. The competition is heating up, and that’s making investors a bit nervous. It’s kinda like when you’re in a race, and suddenly, everyone else speeds up. You start to sweat a little, ya know?

    Also, some predictions out there say Lilly could still hit a much higher price down the line, like $2,090. That’s wild! But with all this back-and-forth, it’s hard to know what to think. Some say things are looking good, while others are feeling cautious. It’s a mixed bag right now.

    One thing to keep an eye on is how Lilly performs in the next earnings report. That’s always a big deal. If they can show strong sales momentum, it could change the game.

    So, that’s the scoop on Eli Lilly today. It’s a bit of a rollercoaster, but hey, that’s the stock market for you! Just remember, this is all for fun and info, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • LLY Today - Jul 13: Analyst Upgrades Boost Sentiment
    2026/07/13
    Hey there! It’s Joey, your friendly neighborhood investor, here to break down how Eli Lilly did today. Spoiler alert: it was a bit of a green day, up just a smidge at 0.22%.

    So, what happened? Well, LLY didn’t exactly have fireworks today, but it didn’t crash and burn either. It kinda just hung around, barely moving. The trading volume was way lower than usual, which usually means people weren’t really rushing to buy or sell.

    Now, why did it move this way? A couple of things were buzzing in the news. Analysts are feeling pretty optimistic about Eli Lilly, especially with the buzz around their new weight-loss drugs and some recent data they presented at a conference. Guggenheim even raised their price target on the stock, which is usually a good sign. People are chatting about how these drugs could really change the game for investors, and that’s got some folks excited. But honestly, the stock’s not moving in wild swings like it has in the past. It seems like investors are kinda waiting to see what’s next.

    Speaking of what's next, Eli Lilly's got some new data on a drug called Kisunla that they just presented. It’s creating a bit of a stir, so keep an eye on that. It could shake things up in the near future.

    Alright, that’s the scoop for today! Eli Lilly is hanging in there, and it looks like analysts are still pretty positive. Just remember, this is all for fun and info—no financial advice here. Catch you later!
    続きを読む 一部表示
    1 分
  • LLY Today - Jul 12: Bearish Options Activity
    2026/07/12
    Hey there! It's Joey, your friendly investor buddy. Just breaking down the day for you. Today, we’re talking about Eli Lilly, and spoiler alert: it was a red day. The stock dropped about 2.3%. Ouch, right?

    So, what happened? LLY got smoked today, dropping by more than 28 bucks. It seems like some investors were hitting that sell button pretty hard. The stock's been on a bit of a rollercoaster lately, and today was definitely not a good ride.

    Now, why did it happen? Well, some chatter around bearish options activity is making folks a bit jittery. Basically, that means a lot of people are betting against the stock, which can really shake things up. There’s this vibe that the market isn’t feeling super confident about Eli Lilly right now. And if you check out the news, some articles are hinting that people are wondering if it’s time to buy, sell, or just hold tight. It’s a mixed bag of opinions out there.

    Also, there’s some buzz around Eli Lilly sharing new data on Kisunla and a blood test for Alzheimer’s at an upcoming conference. That could be a big deal, but today, it wasn’t enough to keep the stock from sliding.

    So, yeah, that one stung for LLY today. Just remember, this is all for fun and info—no financial advice here! Catch you later!
    続きを読む 一部表示
    1 分
  • LLY Today - Jul 11: Mixed signals on growth
    2026/07/11
    Hey there! It’s Joey here, your friendly neighborhood investor. Today, we’re breaking down Eli Lilly, and spoiler alert: it was a red day. The stock dipped about 2.3%. Ouch!

    So, what went down? Well, LLY got smoked today, losing some ground after a pretty mixed bag of news. It opened strong but then drifted down as the day went on. People were hitting that sell button pretty fast, which isn’t the best sign.

    Now, why the drop? There’s chatter about Eli Lilly's premium valuation. Some folks are wondering if it’s really justified given the current growth story. Yeah, that one stung. They’ve got some new data coming out for their Kisunla treatment and an Alzheimer’s blood test, but it seems like investors are a bit skeptical. Plus, their new Foundayo launch hasn’t exactly been setting the world on fire. It’s been described as “muted,” which doesn’t sound too exciting, right?

    On the horizon, they’re gearing up to share that new data at the Alzheimer’s Association International Conference. So, that could shake things up a bit, depending on how it goes.

    To wrap it up, today wasn’t Eli Lilly’s best day. With some mixed signals on growth and a bit of investor hesitation, it’s clear why the stock took a hit. Just remember, this is all for fun and info, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • LLY Today - Jul 10: Stock Slumps on Market Sentiment
    2026/07/10
    Hey there! It’s Joey, your friendly investor buddy, breaking down the day’s stock action. Today, we’re talking about Eli Lilly. Spoiler alert: it was a red day. The stock dropped about 2.7%. Ouch!

    So, what happened? Well, LLY got smoked today, losing a good chunk of its value. It wasn’t just a little dip; it felt like a slow bleed. Volume was lower than usual, too, which usually means people were kinda just sitting this one out.

    Now, why did this happen? A couple of articles pointed to some market sentiment issues. There’s a lot of chatter about Eli Lilly’s future growth, especially with their obesity drug business. While that part is booming, folks seem to be worried about how the overall market is reacting to earnings reports from other companies. You know how it goes—when the bigger market shakes, even solid stocks can feel the tremors.

    One article mentioned that analysts are still pretty bullish on Lilly’s growth, which is a good sign. But right now, it feels like investors are playing it safe and not taking any chances. Nobody really knows for sure why today was such a rough ride, but the market can be unpredictable like that.

    Oh, and just so you know, Eli Lilly’s obesity drug growth is still impressive, and they’re seeing success globally. That’s something to keep an eye on, for sure!

    Alright, folks, that’s a wrap on Eli Lilly today. Just remember, this is all for fun and info, not financial advice. Stay curious and keep those questions coming! Catch you later!
    続きを読む 一部表示
    1 分
  • LLY Today - Jul 09: Slight Move Amid Mixed Signals
    2026/07/09
    Hey there! It’s Joey, your friendly investor buddy, and I’m here to break down what went down with Eli Lilly today. So, LLY had a pretty chill day, barely moving—up just a smidge, like 0.25%.

    So, what happened? Well, the stock kinda just floated around today. It didn’t get smoked, but it wasn’t exactly a party either. Volume was low, too, like way below the average. Seems like folks were keeping it close to the chest, maybe waiting for some juicy news or a spark.

    Now, why did Eli Lilly see this slight uptick? The buzz has been all about predictions and comparisons. Some articles are saying that LLY could hit some nice price points by the end of 2026, which might’ve given a little boost to the stock. Plus, there’s chatter about how Eli Lilly stacks up against other investments, like SpaceX. Some folks think it’s a better bet right now, which could be stirring up some interest.

    And here’s a little nugget for you: there’s some talk about how Eli Lilly is expected to keep pushing forward with their products and research, so that’s something to keep an eye on.

    So, all in all, today was just a quiet day for LLY, but there’s still a lot of chatter happening in the background. Remember, I’m just here to share what’s up, not to give any financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • LLY Today - Jul 09: Small Move, Big Questions
    2026/07/09
    Hey there! It’s Joey here, your friendly neighborhood investor, breaking down the stock scene for today. We’re chatting about Eli Lilly, and it was kind of a mixed bag—LLY was barely in the green, up just a smidge, around a quarter percent.

    So, what went down? The stock didn’t really make waves today. It was one of those days where it just sort of floated along. Volume was way below average, so not a lot of action there. It seems like folks were just chillin’ instead of diving in.

    Now, why did it move like this? Well, there’s chatter in the air. Some articles are pointing out that Eli Lilly is still seen as a solid player in the market, especially compared to other stocks, like SpaceX. That sounds pretty wild, right? People are weighing their options, and some think LLY is a better pick right now. But then there are those predictions floating around about where the stock might land by the end of 2026. Honestly, it’s a mixed bag of opinions, and nobody really knows what’s going to happen next.

    One thing worth keeping an eye on is the wide divide in opinions about LLY’s future. Some think it’s got a bright road ahead, while others are a bit more skeptical. That split could make things interesting as we move forward.

    Alright, that’s a quick rundown for you! Remember, I’m just here to give you the scoop, not tell you what to do with your money. Stay smart, stay curious, and I’ll catch you next time!
    続きを読む 一部表示
    1 分